{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T01:42:20Z","timestamp":1792806140337,"version":"4.5.0"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,3,13]],"date-time":"2021-03-13T00:00:00Z","timestamp":1615593600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["NCT02646371"],"award-info":[{"award-number":["NCT02646371"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eBioMedicine"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.ebiom.2021.103310","type":"journal-article","created":{"date-parts":[[2021,4,15]],"date-time":"2021-04-15T11:55:31Z","timestamp":1618487731000},"page":"103310","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":85,"special_numbering":"C","title":["Human challenge study with a Shigella bioconjugate vaccine: Analyses of clinical efficacy and correlate of protection"],"prefix":"10.1016","volume":"66","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4899-6260","authenticated-orcid":false,"given":"Kawsar R.","family":"Talaat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Alaimo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. Louis","family":"Bourgeois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita M.","family":"Dreyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert W.","family":"Kaminski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chad K.","family":"Porter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subhra","family":"Chakraborty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristen A.","family":"Clarkson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Brubaker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Elwood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahel","family":"Fr\u00f6lich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"DeNearing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hailey","family":"Weerts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7566-5870","authenticated-orcid":false,"given":"Brittany L.","family":"Feijoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane","family":"Halpern","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Sack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark S.","family":"Riddle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronica Gambillara","family":"Fonck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10122","key":"10.1016\/j.ebiom.2021.103310_bib0001","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/S0140-6736(17)33296-8","article-title":"Shigellosis","volume":"391","author":"Kotloff","year":"2018","journal-title":"Lancet"},{"issue":"10051","key":"10.1016\/j.ebiom.2021.103310_bib0002","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1016\/S0140-6736(16)31529-X","article-title":"Use of quantitative molecular diagnostic methods to identify causes of diarrhoea in children: a reanalysis of the GEMS case-control study","volume":"388","author":"Liu","year":"2016","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.ebiom.2021.103310_bib0003","doi-asserted-by":"crossref","first-page":"e564","DOI":"10.1016\/S2214-109X(15)00151-5","article-title":"Pathogen-specific burdens of community diarrhoea in developing countries: a multisite birth cohort study (MAL-ED)","volume":"3","author":"Platts-Mills","year":"2015","journal-title":"Lancet Glob Health"},{"issue":"6","key":"10.1016\/j.ebiom.2021.103310_bib0004","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1542\/peds.73.6.799","article-title":"Effects of diarrhea associated with specific enteropathogens on the growth of children in rural Bangladesh","volume":"73","author":"Black","year":"1984","journal-title":"Pediatrics"},{"issue":"10","key":"10.1016\/j.ebiom.2021.103310_bib0005","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1097\/INF.0000000000000351","article-title":"Effects of Shigella, campylobacter- and ETEC-associated diarrhea on childhood growth","volume":"33","author":"Lee","year":"2014","journal-title":"Pediatr Infect Dis J"},{"issue":"3","key":"10.1016\/j.ebiom.2021.103310_bib0006","doi-asserted-by":"crossref","first-page":"e321","DOI":"10.1016\/S2214-109X(18)30483-2","article-title":"Burden of enterotoxigenic escherichia coli and shigella non-fatal diarrhoeal infections in 79 low-income and lower middle-income countries: a modelling analysis","volume":"7","author":"Anderson","year":"2019","journal-title":"Lancet Glob Health"},{"issue":"12","key":"10.1016\/j.ebiom.2021.103310_bib0007","doi-asserted-by":"crossref","first-page":"e1319","DOI":"10.1016\/S2214-109X(18)30351-6","article-title":"Use of quantitative molecular diagnostic methods to investigate the effect of enteropathogen infections on linear growth in children in low-resource settings: longitudinal analysis of results from the MAL-ED cohort study","volume":"6","author":"Rogawski","year":"2018","journal-title":"Lancet Glob Health"},{"issue":"4","key":"10.1016\/j.ebiom.2021.103310_bib0008","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/j.idc.2019.05.007","article-title":"Antibiotic-resistant enteric infections","volume":"33","author":"Shakoor","year":"2019","journal-title":"Infect Dis Clin North Am"},{"issue":"21","key":"10.1016\/j.ebiom.2021.103310_bib0009","doi-asserted-by":"crossref","first-page":"685","DOI":"10.2307\/4586560","article-title":"Studies of the acute diarrheal diseases; immunization in shigellosis","volume":"63","author":"Hardy","year":"1948","journal-title":"Public Health Rep"},{"key":"10.1016\/j.ebiom.2021.103310_bib0010","first-page":"54","article-title":"Vaccination against bacillary dysentery with ethero-vaccine","volume":"29","author":"Vincent","year":"1921","journal-title":"J of State Med"},{"issue":"9046","key":"10.1016\/j.ebiom.2021.103310_bib0011","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0140-6736(96)06255-1","article-title":"Double-blind vaccine-controlled randomised efficacy trial of an investigational Shigella sonnei conjugate vaccine in young adults","volume":"349","author":"Cohen","year":"1997","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.ebiom.2021.103310_bib0012","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1016\/j.vaccine.2009.12.050","article-title":"Age-related efficacy of Shigella O-specific polysaccharide conjugates in 1-4-year-old Israeli children","volume":"28","author":"Passwell","year":"2010","journal-title":"Vaccine"},{"issue":"36","key":"10.1016\/j.ebiom.2021.103310_bib0013","doi-asserted-by":"crossref","first-page":"4594","DOI":"10.1016\/j.vaccine.2015.06.102","article-title":"Safety and immunogenicity of a candidate bioconjugate vaccine against Shigella dysenteriae type 1 administered to healthy adults: a single blind, partially randomized phase I study","volume":"33","author":"Hatz","year":"2015","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.ebiom.2021.103310_bib0014","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/S1473-3099(17)30108-1","article-title":"Safety, immunogenicity, and preliminary clinical efficacy of a vaccine against extraintestinal pathogenic escherichia coli in women with a history of recurrent urinary tract infection: a randomised, single-blind, placebo-controlled phase 1b trial","volume":"17","author":"Huttner","year":"2017","journal-title":"Lancet Infect Dis"},{"issue":"12","key":"10.1016\/j.ebiom.2021.103310_bib0015","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1128\/CVI.00224-16","article-title":"Safety and Immunogenicity of a candidate bioconjugate vaccine against Shigella flexneri 2a administered to healthy adults: a single-blind, randomized phase I study","volume":"23","author":"Riddle","year":"2016","journal-title":"Clin vaccin immunol CVI"},{"issue":"9","key":"10.1016\/j.ebiom.2021.103310_bib0016","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1080\/21645515.2018.1474316","article-title":"Safety, tolerability and immunogenicity of the ExPEC4V (JNJ-63871860) vaccine for prevention of invasive extraintestinal pathogenic Escherichia coli disease: a phase 1, randomized, double-blind, placebo-controlled study in healthy Japanese participants","volume":"14","author":"Inoue","year":"2018","journal-title":"Hum Vaccin Immunother"},{"issue":"1","key":"10.1016\/j.ebiom.2021.103310_bib0017","first-page":"51","article-title":"Purification and characterization of a Shigella conjugate vaccine, produced by glycoengineering escherichia coli","volume":"26","author":"Ravenscroft","year":"2016","journal-title":"Glycobiology"},{"issue":"2","key":"10.1016\/j.ebiom.2021.103310_bib0018","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1017\/S0950268812001677","article-title":"The Shigella human challenge model","volume":"141","author":"Porter","year":"2013","journal-title":"Epidemiol Infect"},{"issue":"9","key":"10.1016\/j.ebiom.2021.103310_bib0019","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1086\/503039","article-title":"Rifaximin, a nonabsorbed oral antibiotic, prevents shigellosis after experimental challenge","volume":"42","author":"Taylor","year":"2006","journal-title":"Clin infect dis off publ Infect Dis Soc Am"},{"issue":"Supplement_8","key":"10.1016\/j.ebiom.2021.103310_bib0020","doi-asserted-by":"crossref","first-page":"S580","DOI":"10.1093\/cid\/ciz892","article-title":"Consensus report on Shigella controlled human infection model: conduct of studies","volume":"69","author":"Talaat","year":"2019","journal-title":"Clin Infect Dis"},{"issue":"Supplement_8","key":"10.1016\/j.ebiom.2021.103310_bib0021","doi-asserted-by":"crossref","first-page":"S596","DOI":"10.1093\/cid\/ciz909","article-title":"Consensus report on Shigella controlled human infection model: immunological assays","volume":"69","author":"Kaminski","year":"2019","journal-title":"Clin Infect Dis"},{"issue":"Supplement_8","key":"10.1016\/j.ebiom.2021.103310_bib0022","doi-asserted-by":"crossref","first-page":"S591","DOI":"10.1093\/cid\/ciz891","article-title":"Consensus report on Shigella controlled human infection model: clinical endpoints","volume":"69","author":"MacLennan","year":"2019","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.ebiom.2021.103310_bib0023","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0194325","article-title":"Clinical endpoints in the controlled human challenge model for Shigella: a call for standardization and the development of a disease severity score","volume":"13","author":"Porter","year":"2018","journal-title":"PLOS ONE"},{"issue":"12","key":"10.1016\/j.ebiom.2021.103310_bib0024","doi-asserted-by":"crossref","first-page":"6624","DOI":"10.1128\/IAI.68.12.6624-6632.2000","article-title":"Isolation and characterization of a Shigella flexneri invasin complex subunit vaccine","volume":"68","author":"Turbyfill","year":"2000","journal-title":"Infect Immun"},{"issue":"1","key":"10.1016\/j.ebiom.2021.103310_bib0025","doi-asserted-by":"crossref","first-page":"18","DOI":"10.2307\/2527727","article-title":"How to use ridit analysis","volume":"14","author":"Bross","year":"1958","journal-title":"Biometrics"},{"issue":"8","key":"10.1016\/j.ebiom.2021.103310_bib0026","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1093\/infdis\/jiw359","article-title":"Quadrivalent human papillomavirus (HPV) vaccine induces HPV-specific antibodies in the oral cavity: results from the mid-adult male vaccine trial","volume":"214","author":"Pinto","year":"2016","journal-title":"J Infect Dis"},{"issue":"10","key":"10.1016\/j.ebiom.2021.103310_bib0027","doi-asserted-by":"crossref","first-page":"e46916","DOI":"10.1371\/journal.pone.0046916","article-title":"Salivary immune responses to the 7-valent pneumococcal conjugate vaccine in the first 2 years of life","volume":"7","author":"Rodenburg","year":"2012","journal-title":"PLOS ONE"},{"issue":"16","key":"10.1016\/j.ebiom.2021.103310_bib0028","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1016\/0264-410X(95)00102-7","article-title":"A modified Shigella volunteer challenge model in which the inoculum is administered with bicarbonate buffer: clinical experience and implications for Shigella infectivity","volume":"13","author":"Kotloff","year":"1995","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.ebiom.2021.103310_bib0029","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1093\/infdis\/125.1.12","article-title":"Immunity in shigellosis. II. Protection induced by oral live vaccine or primary infection","volume":"125","author":"DuPont","year":"1972","journal-title":"J Infect Dis"},{"issue":"4","key":"10.1016\/j.ebiom.2021.103310_bib0030","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/0264-410X(90)90094-3","article-title":"Studies in volunteers to evaluate candidate Shigella vaccines: further experience with a bivalent salmonella typhi-Shigella sonnei vaccine and protection conferred by previous Shigella sonnei disease","volume":"8","author":"Herrington","year":"1990","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.ebiom.2021.103310_bib0031","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1093\/infdis\/165.4.785","article-title":"Natural immunity to shigellosis in two groups with different previous risks of exposure to Shigella is only partly expressed by serum antibodies to lipopolysaccharide","volume":"165","author":"Cohen","year":"1992","journal-title":"J Infect Dis"},{"issue":"2","key":"10.1016\/j.ebiom.2021.103310_bib0032","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1128\/jcm.29.2.386-389.1991","article-title":"Prospective study of the association between serum antibodies to lipopolysaccharide O antigen and the attack rate of shigellosis","volume":"29","author":"Cohen","year":"1991","journal-title":"J Clin Microbiol"},{"issue":"5","key":"10.1016\/j.ebiom.2021.103310_bib0033","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1086\/516452","article-title":"Characterization and quantitative analysis of serum IgG class and subclass response to Shigella sonnei and Shigella flexneri 2a lipopolysaccharide following natural Shigella infection","volume":"175","author":"Robin","year":"1997","journal-title":"J Infect Dis"},{"issue":"4","key":"10.1016\/j.ebiom.2021.103310_bib0034","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.vaccine.2008.10.081","article-title":"Antigen-specific B memory cell responses to lipopolysaccharide (LPS) and invasion plasmid antigen (Ipa) B elicited in volunteers vaccinated with live-attenuated Shigella flexneri 2a vaccine candidates","volume":"27","author":"Simon","year":"2009","journal-title":"Vaccine"}],"container-title":["eBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396421001031?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396421001031?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T19:33:19Z","timestamp":1778873599000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396421001031"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":34,"alternative-id":["S2352396421001031"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2021.103310","relation":{},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Human challenge study with a Shigella bioconjugate vaccine: Analyses of clinical efficacy and correlate of protection","name":"articletitle","label":"Article Title"},{"value":"eBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2021.103310","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"103310"}}